Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,287,018 papers from all fields of science
Search
Sign In
Create Free Account
NR2C2 wt Allele
Known as:
TR4
, TR2R1
, hTAK1
Expand
Human NR2C2 wild-type allele is located in the vicinity of 3p25 and is approximately 106 kb in length. This allele, which encodes nuclear receptor…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
15 relations
3p25
Androgen Receptor Regulation Pathway
Biologic Development
Cell Differentiation process
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
TR4 nuclear receptor promotes clear cell renal cell carcinoma (ccRCC) vasculogenic mimicry (VM) formation and metastasis via altering the miR490-3p/vimentin signals
Jian Bai
,
S. Yeh
,
+7 authors
Chawnshang Chang
Oncogene
2018
Corpus ID: 49568072
While TR4 nuclear receptor plays key roles to promote prostate cancer progression, its roles to alter the progression of clear…
Expand
2013
2013
Kinase-Independent Feedback of the TAK1/TAB1 Complex on BCL10 Turnover and NF-κB Activation
Miguel E. Moreno-García
,
Karen Sommer
,
+4 authors
D. Rawlings
Molecular and Cellular Biology
2013
Corpus ID: 23837922
ABSTRACT Antigen receptors activate pathways that control cell survival, proliferation, and differentiation. Two important…
Expand
2012
2012
Lys48-linked TAK1 polyubiquitination at lysine-72 downregulates TNFα-induced NF-κB activation via mediating TAK1 degradation.
Yihui Fan
,
Yi Shi
,
+8 authors
Jianhua Yang
Cellular Signalling
2012
Corpus ID: 6872031
2011
2011
Premature aging with impaired oxidative stress defense in mice lacking TR4.
Yi-Fen Lee
,
Su Liu
,
+9 authors
Chawnshang Chang
American Journal of Physiology. Endocrinology and…
2011
Corpus ID: 5443479
Early studies suggest that TR4 nuclear receptor is a key transcriptional factor regulating various biological activities…
Expand
2003
2003
Expression of TAK1, a mediator of TGF-beta and BMP signaling, during mouse embryonic development.
Joy L. Jadrich
,
M. O’Connor
,
E. Coucouvanis
Gene Expression Patterns
2003
Corpus ID: 20730572
2003
2003
Disruption of TR4 Orphan Nuclear Receptor Reduces the Expression of Liver Apolipoprotein E/C-I/C-II Gene Cluster*
Eungseok Kim
,
Shaozhen Xie
,
+9 authors
Chawnshang Chang
Journal of Biological Chemistry
2003
Corpus ID: 27012881
Apolipoprotein E (apoE) is synthesized in many tissues, and the liver is the primary site from which apoE redistributes…
Expand
Review
2002
Review
2002
Recent advances in the TR2 and TR4 orphan receptors of the nuclear receptor superfamily
Yi-Fen Lee
,
Han-Jung Lee
,
Chawnshang Chang
Journal of Steroid Biochemistry and Molecular…
2002
Corpus ID: 11638283
Highly Cited
1997
Highly Cited
1997
Identification of Direct Repeat 4 as a Positive Regulatory Element for the Human TR4 Orphan Receptor
Yi-Fen Lee
,
Huei-ju Pan
,
J. Burbach
,
E. Morkin
,
Chawnshang Chang
Journal of Biological Chemistry
1997
Corpus ID: 33541190
While the TR4 orphan receptor (TR4) is able to repress the expression of its target genes via its interaction with the direct…
Expand
Highly Cited
1995
Highly Cited
1995
Suppression of Gene Expression on the Simian Virus 40 Major Late Promoter by Human TR4 Orphan Receptor
Han-Jung Lee
,
Yifen Lee
,
J. Burbach
,
Chawnshang Chang
Journal of Biological Chemistry
1995
Corpus ID: 40105667
The key expression of the simian virus 40 (SV40) major late promoter could be repressed by the human TR4 orphan receptor via the…
Expand
1995
1995
The orphan receptor TAK1 acts as a repressor of RAR-, RXR- and T3R-mediated signaling pathways.
T. Hirose
,
R. Apfel
,
M. Pfahl
,
A. Jetten
Biochemical and Biophysical Research…
1995
Corpus ID: 32081735
Recently, we reported the cloning and characterization of the novel orphan receptor TAK1. In this study, we analyze the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE